Are we too lenient with immunosuppression in severe cases of Systemic Sclerosis?

Rheumatology (Oxford). 2016 Oct;55(10):1914-6. doi: 10.1093/rheumatology/kew242. Epub 2016 Jun 21.
No abstract available

Publication types

  • Review

MeSH terms

  • Humans
  • Immune Tolerance*
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / therapeutic use*
  • Scleroderma, Systemic* / diagnosis
  • Scleroderma, Systemic* / drug therapy
  • Scleroderma, Systemic* / immunology

Substances

  • Immunosuppressive Agents